Quadrant Capital Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $700K | Sell |
|
|||||
|
2025
Q2 | $1.97M | Sell |
|
|||||
|
2025
Q1 | $2.41M | Buy |
|
|||||
|
2024
Q4 | $241K | Buy |
|
|||||
|
2024
Q3 | $165K | Buy |
|
|||||
|
2024
Q2 | $124K | Sell |
|
|||||
|
2024
Q1 | $210K | Sell |
|
|||||
|
2023
Q4 | $246K | Sell |
|
|||||
|
2023
Q3 | $305K | Sell |
|
|||||
|
2023
Q2 | $380K | Sell |
|
|||||
|
2023
Q1 | $445K | Buy |
|
|||||
|
2022
Q4 | $296K | Sell |
|
|||||
|
2022
Q3 | $248K | Buy |
|
|||||
|
2022
Q2 | $251K | Sell |
|
|||||
|
2022
Q1 | $287K | Buy |
|
|||||
|
2021
Q4 | $235K | Buy |
|
|||||
|
2021
Q3 | $124K | Sell |
|
|||||
|
2021
Q2 | $183K | Buy |
|
|||||
|
2021
Q1 | $191K | Buy |
|
|||||
|
2020
Q4 | $170K | Sell |
|
|||||
|
2020
Q3 | $204K | Buy |
|
|||||
|
2020
Q2 | $134K | Sell |
|
|||||
|
2020
Q1 | $779K | Sell |
|
|||||
|
2019
Q4 | $1.01M | Buy |
|
|||||
|
2019
Q3 | $532K | Buy |
|
|||||
|
2019
Q2 | $543K | Buy |
|
|||||
|
2019
Q1 | $476K | Buy |
|
|||||
|
2018
Q4 | $216K | Buy |
|
|||||
|
2018
Q3 | $37K | Sell |
|
|||||
|
2018
Q2 | $40K | Sell |
|
|||||
|
2018
Q1 | $149K | Sell |
|
|||||
|
2017
Q4 | $176K | Sell |
|
|||||
|
2017
Q3 | $172K | Buy |
|
|||||
|
2017
Q2 | $143K | Buy |
|
|||||
|
2017
Q1 | $118K | Buy |
|
|||||
|
2016
Q4 | $14K | Sell |
|
|||||
|
2016
Q3 | $46K | Buy |
|
|||||
|
2016
Q2 | $3K | Sell |
|
|||||
|
2016
Q1 | $46K | Buy |
|
|||||
|
2015
Q4 | $21K | Buy |
|
|||||
|
2015
Q3 | $1K | Hold |
|
|||||
|
2015
Q2 | $1K | Buy |
|